GSK Investigational Site
				
				Elkridge, Maryland 21075
We've found
        1 trials
        at this facility
      	
	Respiratory Syncytial Virus Infections Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults
		Status: Enrolling,
							Phase
													 I			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	